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 Myosin light chain kinase plays an integral role in initiating and regulating 
smooth muscle contraction. These experiments were conducted to help illuminate and 
better understand the process by which myosin light chain kinase interacts with actin and 
myosin in the ventral stress fibers of permeabilized human airway smooth muscle cells. 
The first 75 residues of the N-terminal end of MLCK (GST tagged N75) contain the three 
DFRXXL motifs, which are sufficient for actin binding  [1-4]. N75 binding to actin was 
imaged using fluorescence microscopy and total internal reflection microscopy under 
varying conditions. N75 binding was inhibited when cells were pre-treated with the S1 
fragment of myosin heads. This suggests that the DFRXXL motifs of MLCK are 
competing with S1 for actin binding sites. These experiments help better the 
understanding of the role myosin light chain kinase plays in the regulation and 
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 Smooth muscle contraction is regulated and initiated by myosin light chain 
kinase. Myosin light chain kinase is a ubiquitous calcium-calmodulin activated kinase 
found in smooth, cardiac and skeletal muscle as well as in mammalian non-muscle 
cells [1]. When myosin light chain kinase is activated, it can phosphorylate Serine 19 of 
the regulatory light chain of smooth muscle myosin [1]. The phosphorylation of smooth 
muscle myosin then activates the actin-activated myosin ATPase activity, which is 
necessary and sufficient for muscle contraction [1]. MLCK is in low abundance relative 
to the amount of myosin it phosphorylates. MLCK is also tightly bound to the contractile 
apparatus and the binding of Ca2+-CaM can be altered by a variety of factors.  At the N-
terminus of myosin light chain kinase is the actin binding site, which is composed of 
three DFRXXL motifs which bind weakly to actin [1-5]. The DFRXXL motifs are 
located at amino acid residues 2-7, 30-35, and 58-63 [4]. Deletion of any of the motifs 
decreases actin binding or eliminates it completely [1-7].  
 N75 is a GST tagged peptide that contains the first 75 amino acids of the N-
terminus of full length MLCK. N75 demonstrates the same actin binding capabilities as 
full length MLCK [4-7]. By imaging and analyzing this peptide’s interaction with actin 
filaments in human smooth muscle cells, the process by which full length MLCK 
interacts with the contractile apparatus and regulates smooth muscle contraction can be 
further understood. A better understanding of how MLCK operates would allow for a 
better molecular module of how smooth muscle contraction is initiated and regulated. 
Such knowledge could play a role in treating diseases such as high blood pressure and 





Preparing Growth Media for Cells 
Cellgro Media M199 was used. 500 ml of media were prepared with final concentrations 
of 10% newborn calf serum, .5ng/ml EGF, and 2ng/ml of FGF. All growth factors were 
purchased from Sigma Aldrich.  
 
Preparing Differentiating Media 
500 ml of Cellgro Media M199 were prepared with final concentrations of .1% newborn 
calf serum, .5 ng/ml EGF, 2 ng/ml FGF, and 1 ng/ml of TGF-Beta1.  
 
Expressing N75 [3] 
GST-N1–75MLCK (the N-terminal actin-binding domain of MLCK, residues 1–75, with 
GST fused to the N-terminus) in pGEX-2TK was expressed in BL21 cells. Cultures (5 l) 
were grown in LB medium to an optical density of 0.4 prior to IPTG (0.1 mM) induction 
for 3 h. Bacterial pellets were suspended in 500 ml phosphate-buffered saline (PBS) 
containing leupeptin (2.5 ug/ml), pepstatin A (2.5 μg/ml), and PMSF (0.1 mM). 
Lysozyme was added to 5 mg/l and the culture was stirred for 30 min at room 
temperature. DTT (5 mM) was added and the mixture was centrifuged at 30,000g for 
45 min; the supernatant was diluted 3-fold with PBS and 5 ml of a 1:1 slurry of 
glutathione-Sepharose 4FF beads in PBS was added. After gentle shaking for 30 min and 
centrifugation at 150g for 5 min, the supernatant was removed and the beads were 
washed with 100 ml PBS. The binding to beads was repeated twice more. The three sets 




volumes of PBS, and eluted with 10 mM glutathione, 50 mM Tris–HCl, pH 8, and 5 mM 
DTT. GST-N1–75MLCK-containing fractions were identified by SDS-PAGE, pooled, and 
dialyzed against 30 mM Tris–HCl, pH 7.5, 20 mM NaCl, 1 mM EGTA, and 0.1 mM 
DTT. Thrombin (Novagen, restriction grade) digestion (8 U/μl) was carried out for 2 h 
at room temperature and stopped by addition of 0.1 mM PMSF. The solution was 
clarified by centrifugation at 39,000g for 30 min. The supernatant was applied to an SP-
Sepharose column (1 cm × 10 cm), equilibrated with 30 mM Tris–HCl, pH 7.5, 20 mM 
NaCl, 1 mM EGTA, and 0.1 mM DTT, at a flow rate of 25 ml/h. After unbound proteins 
were eluted, 0.5 M NaCl in the same buffer followed by a step to 1 M NaCl eluted the N1
–75MLCK. Fractions were identified by NEXT GEL™ (Amresco) electrophoresis (15% 
acrylamide); pooled and dialyzed against 30 mM Tris–HCl, pH 7.5, 20 mM NaCl, 1 mM 
EGTA, and 0.1 mM DTT using 3.5 kDa cutoff dialysis tubing; concentrated in Aquacide 
II; and dialyzed again. Protein concentration was determined by the bicinchoninic acid 
assay. N1–75MLCK has the following sequence (corresponding to the N-terminal domain 
of rabbit smooth muscle 
MLCK):LVPR/GSRRASVGSGGGMDFRANLQRQVKPKTVSEEERKVHSPQQVDF
RSVL-AKKGTPKTPVPEKAPPPKPATPDFRSVLGSKKKLPAENGS. Mr = 9348 after 
thrombin cleavage. The / indicates a thrombin cleavage site, an engineered PKA 
phosphorylation site is underlined, and a linker to the beginning of the MLCK sequence 






Preparing Human Airway Smooth Muscle Cells for Imaging 
Cells were plated on a .045 mg/ml collagen coated coverslip and allowed to differentiate 
for 3 days in differentiating growth media. Flow cells were created using the coverslip 
and microscope slides. Cells were then permeabilized with .1% triton and stained with .5 
Mm trit-c.  
 
Protocol for Imaging Cells and GST. 
All washes were done with 85 microliters of fluid. N75 (1uM) and S1 were allowed to 
incubate for 15 minutes. Actin buffer contained 1/10th volume of actin polymerization 
buffer, 0.5 mM DTT. The concentration of the quantum dots was .25 nM and were 
incubated in the cells for 1 min. Observation buffer contained 100 ul of 10x buffer A, 500 
ul of methyl cellulose, 380 ul water, 20 ul O2 scavengers. Imaging was done at 4 degrees 
Celsius. Observation buffer 2 contained 362 ul water, 18 ul of 111.7 mm ATP (2mM 
final concentration) 100 ul of 10x buffer A, 500 ul of methyl cellulose, and 20 ul O2 
scavengers. Skeletal S1 was at a concentration of 37uM in buffer F.  For figure 1, the 
protocol for imaging slides was as follows: N75 was added, then a wash with actin 
buffer, added Quantum Dots, then a wash with actin buffer, then adding observation 
buffer. For figure 2, the protocol for imaging slides was as follows: S1 added, then a 
wash with actin buffer, add N75, wash with actin buffer, add Quantum Dots, wash with 
actin buffer, then observation buffer. For figure 3, the protocol for imaging slides was as 
follows: NEM-S1 added, a wash with actin buffer, N75 added, wash with actin buffer, 
add Quantum Dots, wash with Actin Buffer, add observation buffer. For figure 4, the 




N75, wash with actin buffer, add Quantum Dots, wash with actin buffer, add observation 
buffer, flow in 3 ul of 111.7 mM ATP (During Imaging). For figure 5, the protocol for 
imaging slides was as follows: S1 added, wash with actin buffer, add N75, wash with 
actin buffer, add Quantum Dots, wash with actin buffer, add observation buffer 
(Contained 2mM ATP). For figure 6, the protocol for imaging slides was as follows: S1 
added, wash with actin buffer, add N75, wash with actin buffer, add Quantum Dots, wash 
with actin buffer, add observation buffer (contained 2mM ATP), flow in N75 at time = 0 
(during imaging).  
 
Analyzing Cell Images and Movies 
Movies were prepared using ImageJ.  
 
Buffers. Actin buffer is 50 mM KCl, 50 mM imidazole (pH 7.4), 2 mM EGTA, 8 mM 
MgCl2, 10 mM DTT, Actin imaging buffer is actin buffer with added oxygen scavengers 
(0.1 mg/ml glucose oxidase, 0.018 mg ml-1catalase, 2.3 mg ml-1 glucose) and 0.5 % 
methylcellulose. Buffer a is 150 mM KCl, 4 mM MgCl2, 2 mM EGTA, 10 mM DTT, 25 
mM imidazole (pH 7.0). If used during imaging, the buffers also contained 0.5% 
methylcellulose and oxygen scavengers as above. 
 
Microscopy. Images of fluorescent actin were recorded using a Nikon TE2000 
epifluorescence microscope (Technical Instruments, CA) with a Roper Cascade 512B 
camera (Princeton Instruments, Trenton, NJ) with a 100X objective. Widefield excitation 




emission filter. Image sequences (movies) of QD-labeled proteins were observed for 1-2 
min by total internal reflection fluorescence (TIRF) using a 488 nm excitation 
wavelength. The frame rate for the TIRF movies was 5 s-1. The merged images of the QD 
signal with TRITC signal from actin were generated using Image J (National Institute of 
Healthy, Bethesda, MD, USA). Movies or images were 512 x 512 pixels at a resolution 











  1B. 
Figure 1. Colocalization of N75 to Stress Fibers in Human Airway Smooth Muscle 
Cells. N75 was allowed to bind for 15 minutes in permeablized cells before being washed 
out. The peptide was visualized through the use of quantum dots that contained strept 
avidin, which bound to biotin groups attached to the N75. The stress fibers are red and 












  2B. 
Figure 2. S1 Decreasing N75 Binding on Stress Fibers. Skeletal S1 was added to the 
cells before N75. There was a significant decrease in binding when stress fibers were pre 















  3B. 
Figure 3. NEM-S1 Decreasing N75 Binding on Stress Fibers. NEM-S1 binds strongly 
to actin even in the presence of ATP. NEM-S1 was allowed to bind to the cells before 












  4B. 
Figure 4. N75 Binding After NEM-S1 Allowed to Bind and ATP Added. NEM-S1 
then N75 was allowed to bind to the stress fibers of the cell. During imaging, 3ul of 111.7 
mM pure ATP was flowed into the cells to see if there would be an increase in N75 
binding due to the dissociation of NEM-S1. There didn’t seem to be a large increase in 














  5B 
 
Figure 5. Change in Binding When S1 Added to Cells With ATP in Imaging Buffer. 
S1 was added to the cells before N75. ATP (2mM) was in the observation buffer. The 
images show the change in binding of N75 after one hour. There seems to be a slight 
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Figure 6. Change in Binding When ATP Added After S1 and Additional N75 
Flowed Into Cell. S1 was allowed to bind before N75. ATP (2mM) was in the 
observation buffer. During imaging, additional N75 (premixed with quantum dots) was 
flowed into the cell. Movies of the change in binding were taken for 10 minutes apart for 





Figure 7. Change in N75 Binding in Cells with S1 and ATP Over 40 Minute Period. 
The experiment from figure 7 was repeated in six different cells on two separate days. At 
the start of the forty-minute period, additional N75 was flowed into the cells, which were 
pre-treated with S1 and had ATP added through the observation buffer. Binding events 
were measured by creating Z-stack images from the movies and counting the total 
number of quantum dots in each Z-stack. The average increase in binding and standard 





























Figure 1 shows cells that were treated with N75 for fifteen minutes and no S1. The 
peptide is clearly seen colocalizing to the stress fibers of the human airway smooth 
muscle cells. Figure 2 shows cells that were treated with S1 for fifteen minutes and then 
N75. There was a significant decrease in colocalization of the peptide to the stress fibers 
of the cells. This suggests that the binding site for myosin and S1 may be located closer 
to each other than previously believed. In order to test this, additional experiments were 
performed to tests whether S1 binding was influencing N75 binding. Figure 3 shows 
stress fibers that were treated with NEM-S1 for fifteen minutes before N75 was added. 
NEM-S1 binds strongly to actin and doesn’t dissociate in the presence of ATP. The 
NEM-S1 showed similar results as the S1 treated cells. There was a significant decrease 
in N75 colocalization to the stress fibers of the cells. To test whether the NEM-S1 would 
continue to influence N75 binding even in the presence of ATP, 3 ul of 111.7 mM ATP 
was flowed into the cells during imaging. As expected, there didn’t see to be a large 
change in binding. Figure 5 shows the change in binging over a one-hour period in cells 
that were treated with S1before N75 and had ATP added in the observation buffer 2(mM 
final concentration). There seems to be a slight increase in N75 binding, suggesting that 
the ATP is causing the S1 heads to dissociate from the stress fibers and allow N75 to 
interact. Figure 6 shows the change in binding of N75 when S1 was allowed to bind in 
the cells first and ATP (2mM final concentration) was in the observation buffer. During 
imaging, additional N75 was flowed into the cells. The slight increase in binding suggests 
that ATP was weakening the S1 interaction with actin in the stress fibers, which allowed 




end of the imaging period, there is almost twice as many binding events. These most 
likely occurred from some quantum dots showing up better in later movies but were 
undistinguishable in earlier movies. 
 
Discussion 
Previous studies have shown that all three DFRXXL regions are important for actin 
binding [4]. An unresolved issue has been whether the motifs bind directly to F-actin in 
smooth muscle myofilaments or in actin containing stress fibers in cells. The significant 
decrease in binding seen in Figure 2 suggests that these regions do directly bind to actin 
containing stress fibers because S1 has effectively stopped the peptide and actin from 
interacting. Previous studies also suggest that the three DFRXXL motifs each bind one 
actin monomer in actin filaments [5, 7]. Previous studies also suggests that the binding 
site of MLCK is distinct from any other actin binding protein and that this unique binding 
site hasn’t had another actin binding protein localized to the site [4, 5, 7]. The results of 
this study show that N75 and S1 compete for binding sites. This is suggested by the 
decrease in N75 binding after S1 was allowed to bind. It’s also suggested by the slight 
increase in peptide binding when ATP is introduced to the cells and causes S1 to 
dissociate. The difference between the referenced studies and these experiments was the 
use of stress fibers in human airway smooth muscle cells instead of purified F-actin. 
Future experiments to further investigate the binding sites of S1 and N75 would be to 
repeat the experiments on purified F-actin or add N75 to the stress fibers and then 
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